2YY1 - Header Asymmetric Unit

HEADER SUGAR BINDING PROTEIN 27-APR-07 2YY1

TITLE CRYSTAL STURCTURE OF N-TERMINAL DOMAIN OF HUMAN GALECTIN-9 TITLE 2 CONTAINING L-ACETYLLACTOSAMINE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN, UNP RESIDUES 1-147; COMPND 5 SYNONYM: HOM-HD-21, ECALECTIN; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CELL-FREE PROTEIN SYNTHESIS; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PK060220-05

KEYWDS SUGER BINDING, GALECTIN, HUMAN, STRUCTURAL GENOMICS, NPPSFA, KEYWDS 2 NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, KEYWDS 4 RSGI, SUGAR BINDING PROTEIN

EXPDTA X-RAY DIFFRACTION

AUTHOR S.KISHISHITA,A.NISHINO,K.MURAYAMA,T.TERADA,M.SHIROUZU, AUTHOR 2 S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE AUTHOR 3 (RSGI)

REVDAT 2 24-FEB-09 2YY1 1 VERSN REVDAT 1 29-APR-08 2YY1 0

JRNL AUTH S.KISHISHITA,A.NISHINO,K.MURAYAMA,T.TERADA, JRNL AUTH 2 M.SHIROUZU,S.YOKOYAMA JRNL TITL CRYSTAL STURCTURE OF N-TERMINAL DOMAIN OF HUMAN JRNL TITL 2 GALECTIN-9 CONTAINING L-ACETYLLACTOSAMINE JRNL REF TO BE PUBLISHED JRNL REFN

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 120533.100 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 13808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 686 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1818 REMARK 3 BIN R VALUE (WORKING SET) : 0.2070 REMARK 3 BIN FREE R VALUE : 0.2410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1105 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : 1.09000 REMARK 3 B33 (A**2) : -2.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 28.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.81 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.310 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.980 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 62.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LACTO.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LACTO.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING.

REMARK 4 REMARK 4 2YY1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-JUL-07. REMARK 100 THE RCSB ID CODE IS RCSB027277.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15074 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 12.899 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 46.3176 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 78.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS.

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM ACETATE TRIHYDRATE, REMARK 280 0.1M SODIUM CACODYLATE, 30% PEG 8000, 30MM L- REMARK 280 ACETYLLACTOSAMINE, PH 6.9, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.80450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 23.70350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.40225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 23.70350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 91.20675 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 23.70350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.40225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 23.70350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 23.70350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 91.20675 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 60.80450 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS STRUCTURE INDICATES MONOMER STRUCTURE IN THIS REMARK 300 CRYSTAL PACKING. BUT, THERE IS NO EXPERIMENTAL EVIDENCE.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 60.80450

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 GLY A 7 REMARK 465 MET A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 SER A 13 REMARK 465 SER A 155 REMARK 465 GLY A 156 REMARK 465 PRO A 157 REMARK 465 SER A 158 REMARK 465 SER A 159 REMARK 465 GLY A 160

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 47 5.04 98.18 REMARK 500 SER A 48 -100.90 -94.28 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 224 DISTANCE = 7.19 ANGSTROMS

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NLC A 161

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001002697.1 RELATED DB: TARGETDB

DBREF 2YY1 A 8 154 UNP O00182 LEG9_HUMAN 1 147

SEQADV 2YY1 GLY A 1 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 2 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 3 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 4 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 5 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 6 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 7 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 155 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 156 UNP O00182 EXPRESSION TAG SEQADV 2YY1 PRO A 157 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 158 UNP O00182 EXPRESSION TAG SEQADV 2YY1 SER A 159 UNP O00182 EXPRESSION TAG SEQADV 2YY1 GLY A 160 UNP O00182 EXPRESSION TAG

SEQRES 1 A 160 GLY SER SER GLY SER SER GLY MET ALA PHE SER GLY SER SEQRES 2 A 160 GLN ALA PRO TYR LEU SER PRO ALA VAL PRO PHE SER GLY SEQRES 3 A 160 THR ILE GLN GLY GLY LEU GLN ASP GLY LEU GLN ILE THR SEQRES 4 A 160 VAL ASN GLY THR VAL LEU SER SER SER GLY THR ARG PHE SEQRES 5 A 160 ALA VAL ASN PHE GLN THR GLY PHE SER GLY ASN ASP ILE SEQRES 6 A 160 ALA PHE HIS PHE ASN PRO ARG PHE GLU ASP GLY GLY TYR SEQRES 7 A 160 VAL VAL CYS ASN THR ARG GLN ASN GLY SER TRP GLY PRO SEQRES 8 A 160 GLU GLU ARG LYS THR HIS MET PRO PHE GLN LYS GLY MET SEQRES 9 A 160 PRO PHE ASP LEU CYS PHE LEU VAL GLN SER SER ASP PHE SEQRES 10 A 160 LYS VAL MET VAL ASN GLY ILE LEU PHE VAL GLN TYR PHE SEQRES 11 A 160 HIS ARG VAL PRO PHE HIS ARG VAL ASP THR ILE SER VAL SEQRES 12 A 160 ASN GLY SER VAL GLN LEU SER TYR ILE SER PHE SER GLY SEQRES 13 A 160 PRO SER SER GLY

HET NLC A 161 26

HETNAM NLC 2-(ACETYLAMINO)-2-DEOXY-4-O-BETA-D-GALACTOPYRANOSYL- HETNAM 2 NLC ALPHA-D-GLUCOPYRANOSE

FORMUL 2 NLC C14 H25 N O11 FORMUL 3 HOH *63(H2 O)

HELIX 1 1 PRO A 134 VAL A 138 5 5

SHEET 1 A 6 TYR A 17 LEU A 18 0 SHEET 2 A 6 VAL A 147 SER A 153 -1 O ILE A 152 N TYR A 17 SHEET 3 A 6 GLN A 37 VAL A 44 -1 N ASN A 41 O SER A 150 SHEET 4 A 6 PRO A 105 VAL A 112 -1 O PHE A 110 N ILE A 38 SHEET 5 A 6 ASP A 116 VAL A 121 -1 O MET A 120 N CYS A 109 SHEET 6 A 6 ILE A 124 PHE A 130 -1 O PHE A 126 N VAL A 119 SHEET 1 B 6 PHE A 24 THR A 27 0 SHEET 2 B 6 THR A 140 GLY A 145 -1 O VAL A 143 N PHE A 24 SHEET 3 B 6 PHE A 52 GLN A 57 -1 N ASN A 55 O SER A 142 SHEET 4 B 6 ILE A 65 ARG A 72 -1 O PHE A 69 N VAL A 54 SHEET 5 B 6 TYR A 78 GLN A 85 -1 O VAL A 80 N ASN A 70 SHEET 6 B 6 SER A 88 TRP A 89 -1 O SER A 88 N GLN A 85 SHEET 1 C 6 PHE A 24 THR A 27 0 SHEET 2 C 6 THR A 140 GLY A 145 -1 O VAL A 143 N PHE A 24 SHEET 3 C 6 PHE A 52 GLN A 57 -1 N ASN A 55 O SER A 142 SHEET 4 C 6 ILE A 65 ARG A 72 -1 O PHE A 69 N VAL A 54 SHEET 5 C 6 TYR A 78 GLN A 85 -1 O VAL A 80 N ASN A 70 SHEET 6 C 6 GLU A 93 LYS A 95 -1 O LYS A 95 N VAL A 79

CISPEP 1 VAL A 22 PRO A 23 0 0.11

SITE 1 AC1 8 HIS A 68 ASN A 70 ARG A 72 ASN A 82 SITE 2 AC1 8 GLU A 92 ILE A 124 HOH A 196 HOH A 204

CRYST1 47.407 47.407 121.609 90.00 90.00 90.00 P 41 21 2 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.021094 0.000000 0.000000 0.00000

SCALE2 0.000000 0.021094 0.000000 0.00000

SCALE3 0.000000 0.000000 0.008223 0.00000